nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethynodiol—PGR—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.0708	0.0722	CbGpPWpGaD
Ethynodiol—PGR—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.0559	0.0571	CbGpPWpGaD
Ethynodiol—PGR—Nuclear signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.0554	0.0565	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.0416	0.0424	CbGpPWpGaD
Ethynodiol—ESR1—Signaling mediated by p38-alpha and p38-beta—RAB5A—amyotrophic lateral sclerosis	0.0413	0.0421	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—GRN—amyotrophic lateral sclerosis	0.0346	0.0353	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.0328	0.0335	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.0325	0.0332	CbGpPWpGaD
Ethynodiol—PGR—Nuclear signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.0288	0.0294	CbGpPWpGaD
Ethynodiol—ESR1—LKB1 signaling events—MAPT—amyotrophic lateral sclerosis	0.0259	0.0264	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.0243	0.0248	CbGpPWpGaD
Ethynodiol—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—amyotrophic lateral sclerosis	0.0226	0.0231	CbGpPWpGaD
Ethynodiol—PGR—Validated nuclear estrogen receptor alpha network—SOD1—amyotrophic lateral sclerosis	0.0203	0.0207	CbGpPWpGaD
Ethynodiol—Progesterone—SIGMAR1—amyotrophic lateral sclerosis	0.0194	1	CrCbGaD
Ethynodiol—PGR—Signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.0187	0.019	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.0184	0.0188	CbGpPWpGaD
Ethynodiol—ESR1—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—amyotrophic lateral sclerosis	0.0173	0.0177	CbGpPWpGaD
Ethynodiol—ESR1—Nuclear signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.0169	0.0172	CbGpPWpGaD
Ethynodiol—PGR—Validated nuclear estrogen receptor alpha network—C3—amyotrophic lateral sclerosis	0.0161	0.0164	CbGpPWpGaD
Ethynodiol—ESR1—FOXA1 transcription factor network—SOD1—amyotrophic lateral sclerosis	0.0161	0.0164	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.0142	0.0145	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.014	0.0143	CbGpPWpGaD
Ethynodiol—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—amyotrophic lateral sclerosis	0.0119	0.0122	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.0117	0.0119	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.0114	0.0116	CbGpPWpGaD
Ethynodiol—PGR—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.0113	0.0116	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.011	0.0112	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.0108	0.011	CbGpPWpGaD
Ethynodiol—ESR1—Plasma membrane estrogen receptor signaling—IGF1—amyotrophic lateral sclerosis	0.0104	0.0106	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00994	0.0101	CbGpPWpGaD
Ethynodiol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—amyotrophic lateral sclerosis	0.00977	0.00996	CbGpPWpGaD
Ethynodiol—PGR—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.0097	0.00989	CbGpPWpGaD
Ethynodiol—PGR—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.00966	0.00985	CbGpPWpGaD
Ethynodiol—ESR1—Validated nuclear estrogen receptor alpha network—C3—amyotrophic lateral sclerosis	0.00945	0.00963	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00886	0.00903	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00785	0.00801	CbGpPWpGaD
Ethynodiol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.00785	0.008	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00762	0.00777	CbGpPWpGaD
Ethynodiol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—amyotrophic lateral sclerosis	0.00755	0.0077	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00717	0.00731	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.00702	0.00716	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00686	0.00699	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00668	0.00682	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.00665	0.00678	CbGpPWpGaD
Ethynodiol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.00618	0.00631	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.00614	0.00626	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00583	0.00595	CbGpPWpGaD
Ethynodiol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.00581	0.00593	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—FUS—amyotrophic lateral sclerosis	0.00571	0.00582	CbGpPWpGaD
Ethynodiol—ESR1—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.00569	0.0058	CbGpPWpGaD
Ethynodiol—ESR1—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.00567	0.00578	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00554	0.00565	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.00553	0.00564	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.0052	0.0053	CbGpPWpGaD
Ethynodiol—ESR1—LKB1 signaling events—TP53—amyotrophic lateral sclerosis	0.00493	0.00503	CbGpPWpGaD
Ethynodiol—ESR1—AP-1 transcription factor network—MMP9—amyotrophic lateral sclerosis	0.00492	0.00502	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00467	0.00476	CbGpPWpGaD
Ethynodiol—PGR—Gene Expression—RARA—amyotrophic lateral sclerosis	0.00465	0.00474	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00446	0.00455	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.0036	0.00367	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—FUS—amyotrophic lateral sclerosis	0.00335	0.00342	CbGpPWpGaD
Ethynodiol—ESR1—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	0.00334	0.0034	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.00324	0.00331	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00316	0.00322	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.00303	0.00309	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00297	0.00303	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00282	0.00287	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00281	0.00287	CbGpPWpGaD
Ethynodiol—ESR1—Gene Expression—RARA—amyotrophic lateral sclerosis	0.00273	0.00278	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00272	0.00278	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.00251	0.00256	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00242	0.00247	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00239	0.00244	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.00239	0.00244	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00233	0.00238	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.00198	0.00202	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00185	0.00189	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.00181	0.00184	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00174	0.00178	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00165	0.00168	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00164	0.00168	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.0016	0.00163	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00154	0.00157	CbGpPWpGaD
Ethynodiol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.0015	0.00153	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00147	0.0015	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00142	0.00145	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.0014	0.00143	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.00126	0.00128	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.00118	0.0012	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00104	0.00106	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000972	0.000991	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000964	0.000983	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000904	0.000922	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000861	0.000878	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000803	0.000819	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000737	0.000752	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000693	0.000707	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000618	0.00063	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000613	0.000625	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000584	0.000596	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.00057	0.000582	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000524	0.000535	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000471	0.000481	CbGpPWpGaD
Ethynodiol—PGR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000396	0.000404	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000363	0.00037	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000343	0.00035	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000308	0.000314	CbGpPWpGaD
Ethynodiol—ESR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000233	0.000237	CbGpPWpGaD
